Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$242.49 - $301.46 $563,789 - $700,894
-2,325 Reduced 10.72%
19,360 $4.75 Million
Q2 2022

Aug 11, 2022

SELL
$224.73 - $338.64 $222,033 - $334,576
-988 Reduced 4.36%
21,685 $5.37 Million
Q1 2022

May 09, 2022

BUY
$277.25 - $366.29 $26,338 - $34,797
95 Added 0.42%
22,673 $7.51 Million
Q4 2021

Feb 04, 2022

BUY
$300.63 - $371.35 $452,448 - $558,881
1,505 Added 7.14%
22,578 $8.11 Million
Q3 2021

Nov 08, 2021

BUY
$310.19 - $376.2 $378,431 - $458,964
1,220 Added 6.15%
21,073 $6.86 Million
Q2 2021

Aug 13, 2021

BUY
$262.71 - $351.17 $5.22 Million - $6.97 Million
19,853 New
19,853 $6.2 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.